Third, the modest sample sizes limited statistical power for detailed subgroup/stratified analyses (e.g., by ESRD etiology, comorbidity profiles, or anemia/mineral‐bone disorder markers such as hemoglobin and PTH). The gene discussed is PTH; the disease is anemia.